Lipopolysaccharide/adenosine triphosphate induces IL-1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 341-349

  Xie, Qiang ^a,b   Shen, Wen Wen ^a   Zhong, Jian ^a   Huang, Cheng ^a   Zhang, Lei ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Caspase 1; Inflammasome; Interleukin 18; Interleukin 1 ; NOD like receptor family; Pyrin domain containing 3; RAW264.7 cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CASPASE RECRUITMENT DOMAIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; MESSENGER RNA; NOD LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3; POTASSIUM CHLORIDE; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE; PYCARD PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CYTOKINE RELEASE; DANGER ASSOCIATED MOLECULAR PATTERN; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; INFLAMMATION; MACROPHAGE; MOLECULAR BIOLOGY; MOLECULE; MOUSE; NONHUMAN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASPASE 1; CELL LINE; GENE EXPRESSION REGULATION; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTERLEUKINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; POTASSIUM CHLORIDE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84902655345     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1755     Document Type: Article

References (51)

1. Martinon F, Mayor A and Tschopp J: The inflammasomes: guardians of the body. Annu Rev Immunol 27: 229-265, 2009.
2. Franchi L, Eigenbrod T and Núñez G: Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183: 792-796, 2009.
3. Jin C and Flavell RA: Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 30: 628-631, 2010.
4. Conforti-Andreoni C, Ricciardi-Castagnoli P and Mortellaro A: The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond. Cell Mol Immunol 8: 135-145, 2011.
5. Schroder K and Tschopp J: The inflammasomes. Cell 140: 821-832, 2010.
6. Chen M, Wang H, Chen W and Meng G: Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol 11: 549-554, 2011.
7. Leemans JC, Cassel SL and Sutterwala FS: Sensing damage by the NLRP3 inflammasome. Immunol Rev 243: 152-162, 2011.
8. Davis BK, Wen H and Ting JP: The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735, 2011.
9. Cassel SL, Joly S and Sutterwala FS: The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 21: 194-198, 2009.
10. Hsu HY and Wen MH: Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277: 22131-22139, 2002.
11. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232, 2006. (Pubitemid 43372102)
12. van de Veerdonk FL and Netea MG: New insights in the immunobiology of IL-1 family members. Front Immunol 4: 167, 2013.
13. Qi J, Ye X, Ren G, Kan F, Zhang Y, Guo M, Zhang Z and Li D: Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis. Mol Immunol 57: 59-65, 2014.
14. Voronov E, Dayan M, Zinger H, Gayvoronsky L, Lin JP, Iwakura Y, Apte RN and Mozes E: IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur Cytokine Netw 17: 109-116, 2006.
15. Girardin SE: Knocking in the NLRP3 inflammasome. Immunity 30: 761-763, 2009.
16. Latz E: The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 22: 28-33, 2010.
17. Budai MM, Varga A, Milesz S, Tozser J and Benko S: Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Mol Immunol 56: 471-479, 2013.
18. Hussen J, Düvel A, Koy M and Schuberth HJ: Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7. Dev Comp Immunol 38: 312-320, 2012.
19. Pétrilli V, Papin S, Dostert C, Mayor A, Martinon F and Tschopp J: Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589, 2007. (Pubitemid 47278844)
20. Kawai T and Akira S: Innate immune recognition of viral infection. Nat Immunol 7: 131-137, 2006. (Pubitemid 43135878)
21. Bose S and Banerjee AK: Innate immune response against nonsegmented negative strand RNA viruses. J Interferon Cytokine Res 23: 401-412, 2003. (Pubitemid 37034578)
22. O'Neill LA and Bowie AG: Sensing and signaling in antiviral innate immunity. Curr Biol 20: R328-R333, 2010.
23. Rathinam VA and Fitzgerald KA: Inflammasomes and anti-viral immunity. J Clin Immunol 30: 632-637, 2010.
24. Ciraci C, Janczy JR, Sutterwala FS and Cassel SL: Control of innate and adaptive immunity by the inflammasome. Microbes Infect 14: 1263-1270, 2012.
25. Mankan AK, Dau T, Jenne D and Hornung V: The NLRP3/ASC/Caspase-1 axis regulates IL-1beta processing in neutrophils. Eur J Immunol 42: 710-715, 2012.
26. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM and Gallo RL: NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 284: 12762-12771, 2009.
27. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and Golenbock DT: The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-865, 2008.
28. Zhou R, Tardivel A, Thorens B, Choi I and Tschopp J: Thioredoxin- interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
29. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT and Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677, 2008. (Pubitemid 351928351)
30. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856, 2008.
31. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA and Sutterwala FS: The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105: 9035-9040, 2008.
32. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS and Flavell RA: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126, 2008. (Pubitemid 351871731)
33. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S and Beer HD: The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17: 1140-1145, 2007. (Pubitemid 46990888)
34. Bryant C and Fitzgerald KA: Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 19: 455-464, 2009.
35. McGettrick AF and O'Neill LA: NLRP3 and IL-1beta in macrophages as critical regulators of metabolic diseases. Diabetes Obes Metab 15 (Suppl 3): 19-25, 2013.
36. Lamkanfi M and Dixit VM: Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 227: 95-105, 2009.
37. McCall SH, Sahraei M, Young AB, Worley CS, Duncan JA, Ting JP and Marriott I: Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. J Bone Miner Res 23: 30-40, 2008.
38. Duncan JA, Bergstralh DT, Wang Y, Willingham SB, Ye Z, Zimmermann AG and Ting JP: Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 104: 8041-8046, 2007. (Pubitemid 47185872)
39. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I and Reed JC: Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25: 713-724, 2007. (Pubitemid 46341921)
40. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z and Alnemri ES: The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277: 21119-21122, 2002. (Pubitemid 34952246)
41. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J and Reed JC: Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 171: 6154-6163, 2003. (Pubitemid 37467238)
42. Bryan NB, Dorfleutner A, Kramer SJ, Yun C, Rojanasakul Y and Stehlik C: Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes. J Inflamm (Lond) 7: 23, 2010.
43. Bryan NB, Dorfleutner A, Rojanasakul Y and Stehlik C: Activation of inflammasomes requires intracellular redistri bution of the apoptotic speck-like protein containing a caspase recruitment domain. J Immunol 182: 3173-3182, 2009.
44. Franchi L1, Eigenbrod T, Muñoz-Planillo R and Nuñez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247, 2009.
45. Martinon F and Tschopp J: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574, 2004. (Pubitemid 38692523)
46. Arend WP, Palmer G and Gabay C: IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38, 2008. (Pubitemid 351986169)
47. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF and Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490, 2005. (Pubitemid 41587888)
48. Cayrol C and Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106: 9021-9026, 2009.
49. Bae S, Kang T, Hong J, Lee S, Choi J, Jhun H, Kwak A, Hong K, Kim E, Jo S and Kim S: Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity. J Biol Chem 287: 8205-8213, 2012.
50. Lefrancais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP and Cayrol C: IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109: 1673-1678, 2012.
51. Shaw PJ, McDermott MF and Kanneganti TD: Inflammasomes and autoimmunity. Trends Mol Med 17: 57-64, 2011.